Noha Elserafy

Noha Elserafy

Auto-generated profile, based on publicly available information

Noha Elserafy

Department of Clinical Genetics Nepean Hospital Penrith New South Wales Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2021 in JIMD Reports
Verified
Journal Article
Open access
PDF file
NENoha Elserafy
Noha Elserafy
STSue Thompson
Sue Thompson
TDTroy Dalkeith
Troy Dalkeith
MSMichael Stormon
Michael Stormon
GTGordon Thomas
Gordon Thomas
CECarolyn Ellaway
Carolyn Ellaway
Background: Inborn errors of metabolism (IEM) are a diverse group of genetic disorders that can result in significant morbidity and sometimes death. Metabolic management can be challenging and burdensome for families. Liver transplantation (LT) is increasingly being considered a treatment option for some IEMs. IEMs are now considered the second most common reason for pediatric LT.Aim: To review the data of all children with an IEM who had LT at The Children's Hospital at Westmead (CHW), NSW, Australia between January 1986 and January 2019.Methods: Retrospective data collected from the medical records and genetic files included patient demographics, family history, parental consanguinity, method of diagnosis of IEM, hospital and intensive care unit admissions, age at LT, graft type, clinical outcomes and metabolic management pre and post‐LT.Results: Twenty‐four LT were performed for 21 patients. IEM diagnoses were MSUD (n = 4), UCD (n = 8), OA (n = 6), TYR type I (n = 2) and GSD Ia (n = 1). Three patients had repeat transplants due to complications. Median age at transplant was 6.21 years (MSUD), 0.87 years (UCD), 1.64 years (OA) and 2.2 years (TYR I). Two patients died peri‐operatively early in the series, one died 3 months after successful LT due to septicemia. Eighteen LTs have been performed since 2008 in comparison to six LT prior to 2008. Dietary management was liberalized post LT for all patients.Conclusions: Referral for LT for IEMs has increased over the last 33 years, with the most referrals in the last 10 years. Early LT has resulted in improved clinical outcomes and patient survival.

22 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
CHClara Houdayer
Clara Houdayer
APA Marie Phillips
A Marie Phillips
MCMarie Chabbert
Marie Chabbert
JBJennifer Bourreau
Jennifer Bourreau
RMReza Maroofian
Reza Maroofian
Christian LegrosChristian Legros
Christian Legros
Hyperpolarization activated Cyclic Nucleotide (HCN) gated channels are crucial for various neurophysiological functions, including learning and sensory functions, and their dysfunction are responsible for brain disorders, such as epilepsy. To date, HCN2 variants have only been associated with mild epilepsy and recently, one monoallelic missense variant has been linked to developmental and epileptic encephalopathy. Here, we expand the phenotypic spectrum of HCN2- related disorders by describing twenty-one additional individuals from fifteen unrelated families carrying HCN2 variants. Seventeen individuals had developmental delay/intellectual disability (DD/ID), two had borderline DD/ID, and one had borderline DD. Ten individuals had epilepsy with DD/ID, with median age of onset of 10 months, and one had epilepsy with normal development. Molecular diagnosis identified thirteen different pathogenic HCN2 variants, including eleven missense variants affecting highly conserved amino acids, one frameshift variant, and one in-frame deletion. Seven variants were monoallelic of which five occurred de novo, one was not maternally inherited, one was inherited from a father with mild learning disabilities, and one was of unknown inheritance. The remaining six variants were biallelic, with four homozygous and two compound heterozygous variants. Functional studies using two-electrode voltage-clamp recordings in Xenopus laevis oocytes were performed on three monoallelic variants, p.(Arg324His), p.(Ala363Val), and p.(Met374Leu), and three biallelic variants, p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp). The p.(Arg324His) variant induced a strong increase of HCN2 conductance, while p.(Ala363Val) and p.(Met374Leu) displayed dominant negative effects, leading to a partial loss of HCN2 channel function. By confocal imaging, we found that the p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp) pathogenic variants impaired membrane trafficking, resulting in a complete loss of HCN2 elicited currents in Xenopus oocytes. Structural 3D-analysis in depolarized and hyperpolarized states of HCN2 channels, revealed that the pathogenic variants p.(His205Gln), p.(Ser409Leu), p.(Arg324Cys), p.(Asn369Ser) and p.(Gly460Asp) modify molecular interactions altering HCN2 function. Taken together, our data broadens the clinical spectrum associated with HCN2 variants, and disclose that HCN2 is involved in developmental encephalopathy with or without epilepsy.

30 December 2024 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
RCRaphael Carapito
Raphael Carapito
AMAnne Molitor
Anne Molitor
Lisa PavinatoLisa Pavinato
Lisa Pavinato
ASAlaa Skeyni
Alaa Skeyni
MLMagalie Lambert
Magalie Lambert
SBSeiamak Bahram
Seiamak Bahram

13 August 2026 in Sonography
Verified
Journal Article
Open access
PDF file
DWDeborah Wye
Deborah Wye
LGLaura Gerhardy
Laura Gerhardy
NENoha Elserafy
Noha Elserafy
Genomic medicine is advancing rapidly, bringing significant changes to prenatal care and expanding the role of health professionals. As clinicians responsible for performing prenatal ultrasounds which may detect fetal anomalies and ultimately lead to genetic diagnoses, sonographers should have an understanding of genomic concepts to support a timely diagnosis, optimised patient outcomes, and multidisciplinary care. This article provides an introductory overview of genomics for sonographers, outlining key concepts essential to genomic literacy, testing approaches, and practical strategies to support sonographers in delivering genomically informed care.

1 July 2026 in Kidney360
Verified
Journal Article
Open access
SJSumedh Jayanti
Sumedh Jayanti
ETEsther Ting
Esther Ting
SVSeethalakshmi Viswanathan
Seethalakshmi Viswanathan
NENoha Elserafy
Noha Elserafy
JCJames Clark
James Clark
MKMuralikrishna Gangadharan Komala
Muralikrishna Gangadharan Komala
Hereditary thrombotic thrombocytopenic purpura (TTP) is a rare autosomal recessive disorder caused by ADAMTS13 deficiency, typically presenting in childhood or early adulthood. We describe an atypical presentation of hereditary TTP in a 55-year-old man presenting with AKI on a background of diabetic kidney disease, without suggestive history or identifiable triggers. Initial evaluation revealed features of thrombotic microangiopathy (TMA), including hemolysis, thrombocytopenia, with preserved coagulation parameters. Presumptive complement-mediated TMA was treated with eculizumab; however, the patient progressed to dialysis dependence and developed transient neurologic symptoms. ADAMTS13 activity was reduced (8 U/dl) without a detectable inhibitor, prompting treatment with fresh frozen plasma (FFP), which resulted in hematologic and neurologic improvement. Kidney biopsy demonstrated acute TMA superimposed on advanced diabetic and vascular disease. Genetic testing identified a heterozygous pathogenic ADAMTS13 variant (c.587C>T; p.Thr196Ile) without a second pathogenic allele. Additional long-read sequencing detected polymorphisms that may be associated with reduced ADAMTS13 activity; however, current evidence suggests that these are variants of unknown significance. Although these variants have been associated with variation in ADAMTS13 levels in population or functional studies, the contribution of the additional variants remains uncertain. Functional response to FFP with transient correction of ADAMTS13 levels supported a diagnosis of hereditary TTP. The patient was commenced on regular FFP infusions and has been stable without further hematologic or neurologic events. He remains dialysis dependent, awaiting kidney transplantation. This case highlights a late-onset, atypical presentation of hereditary TTP and raises important questions regarding the pathogenicity of heterozygous variants and modifying polymorphisms. It underscores the need to consider ADAMTS13 deficiency in unexplained TMA and kidney failure, even in the absence of classic features or biallelic mutations.